ENvue Medical, Inc. (FEED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-500K 0 500K 1M 1.5M Q1 '14: -62K Q2 '14: 64K Q3 '14: 25K Q4 '14: 52K Q1 '15: 29K Q2 '15: 39K Q3 '15: 40K Q4 '15: 39K Q1 '16: 57K Q2 '16: 62K Q3 '16: 61K Q4 '16: 49K Q1 '17: 52K Q2 '17: 52K Q3 '17: 65K Q4 '17: 70K Q1 '18: 77K Q2 '18: 132K Q3 '18: 54K Q4 '18: 54K Q1 '19: 79K Q2 '19: 263K Q3 '19: 101K Q4 '19: 87K Q1 '20: 114K Q2 '20: 269K Q3 '20: 150K Q4 '20: 90K Q1 '21: 103K Q2 '21: 318K Q3 '21: 499K Q4 '21: 775K Q1 '22: 272K Q2 '22: 485K Q3 '22: 97K Q1 '23: 354K Q2 '23: 294K Q3 '23: 458K Q4 '23: 1.2M Q1 '24: 921K Q2 '24: 817K Q3 '24: 376K Q4 '24: 444K Q1 '25: 1M Q2 '25: 494K Q3 '25: 722K Q4 '25: 312K Q1 '26: 653K Q2 '26: 239K Q3 '15 Q2 '17 Q1 '19 Q4 '20 Q3 '22 Q3 '24 Q2 '26

Gross Profit Quarterly

-600K -300K 0 300K 600K 900K Q1 '14: -40K Q2 '14: 39K Q3 '14: -10K Q4 '14: 41K Q1 '15: 19K Q2 '15: 24K Q3 '15: 30K Q4 '15: 25K Q1 '16: 30K Q2 '16: 40K Q3 '16: 34K Q4 '16: 38K Q1 '17: 36K Q2 '17: 34K Q3 '17: 43K Q4 '17: 38K Q1 '18: 55K Q2 '18: 77K Q3 '18: 8K Q4 '18: 19K Q1 '19: 53K Q2 '19: 207K Q3 '19: 47K Q1 '20: 51K Q2 '20: 38K Q3 '20: 99K Q4 '20: 26K Q1 '21: 77K Q2 '21: 208K Q3 '21: 228K Q4 '21: 257K Q1 '22: 106K Q2 '22: 281K Q3 '22: 80K Q1 '23: 235K Q2 '23: 216K Q3 '23: 349K Q4 '23: 737K Q1 '24: 664K Q2 '24: 428K Q3 '24: 133K Q4 '24: 283K Q1 '25: 369K Q2 '25: -35K Q3 '25: 189K Q4 '25: -370K Q1 '26: -55K Q2 '26: -266K Q2 '15 Q4 '16 Q2 '18 Q1 '20 Q3 '21 Q2 '23 Q4 '24 Q2 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q1 '14: 144K Q2 '14: -268K Q3 '14: -518K Q4 '14: -281K Q1 '15: -311K Q2 '15: -315K Q3 '15: -338K Q4 '15: -460K Q1 '16: -474K Q2 '16: -456K Q3 '16: -545K Q4 '16: -841K Q1 '17: -802K Q2 '17: -660K Q3 '17: -613K Q4 '17: -1M Q1 '18: -790K Q2 '18: -825K Q3 '18: -1.3M Q4 '18: -1.4M Q1 '19: -2.2M Q2 '19: -896K Q3 '19: -793K Q4 '19: -1.2M Q1 '20: -907K Q2 '20: -1.5M Q3 '20: -804K Q4 '20: -1.5M Q1 '21: -1.3M Q2 '21: -991K Q3 '21: -868K Q4 '21: -2.5M Q1 '22: -1.1M Q2 '22: -1.3M Q3 '22: -924K Q4 '22: -1.7M Q1 '23: -1.1M Q2 '23: -1M Q3 '23: -670K Q4 '23: -702K Q1 '24: -568K Q2 '24: -674K Q3 '24: -970K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: -2.2M Q4 '25: -14.8M Q1 '26: -3.7M Q2 '26: -5.5M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '14: -503K Q2 '14: -578K Q3 '14: -766K Q4 '14: -800K Q1 '15: -630K Q2 '15: -434K Q3 '15: -1M Q4 '15: -781K Q1 '16: -495K Q2 '16: -610K Q3 '16: -606K Q4 '16: -1.1M Q1 '17: -877K Q2 '17: -849K Q3 '17: -1.6M Q4 '17: -1.6M Q1 '18: -789K Q2 '18: -824K Q3 '18: -1.3M Q4 '18: -1.2M Q1 '19: -2.7M Q2 '19: -1.1M Q3 '19: -815K Q4 '19: -1.2M Q1 '20: -921K Q2 '20: -1.5M Q3 '20: -922K Q4 '20: -1M Q1 '21: -4.9M Q2 '21: -216K Q3 '21: -6.7M Q4 '21: -2.5M Q1 '22: -1.1M Q2 '22: -1.3M Q3 '22: -955K Q4 '22: -2.1M Q1 '23: -1.1M Q2 '23: -1.1M Q3 '23: -727K Q4 '23: -813K Q1 '24: -588K Q2 '24: -688K Q3 '24: -998K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: 510K Q4 '25: -12.9M Q1 '26: -3.8M Q2 '26: -4.9M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q1 '14: 22K Q2 '14: 25K Q3 '14: 35K Q4 '14: 11K Q1 '15: 10K Q2 '15: 15K Q3 '15: 10K Q4 '15: 14K Q1 '16: 27K Q2 '16: 22K Q3 '16: 27K Q4 '16: 11K Q1 '17: 16K Q2 '17: 18K Q3 '17: 22K Q4 '17: 32K Q1 '18: 22K Q2 '18: 55K Q3 '18: 46K Q4 '18: 35K Q1 '19: 26K Q2 '19: 56K Q3 '19: 54K Q4 '19: 113K Q1 '20: 63K Q2 '20: 231K Q3 '20: 51K Q4 '20: 64K Q1 '21: 26K Q2 '21: 110K Q3 '21: 271K Q4 '21: 518K Q1 '22: 166K Q2 '22: 204K Q3 '22: 17K Q4 '22: 198K Q1 '23: 119K Q2 '23: 78K Q3 '23: 109K Q4 '23: 440K Q1 '24: 257K Q2 '24: 389K Q3 '24: 243K Q4 '24: 161K Q1 '25: 656K Q2 '25: 529K Q3 '25: 533K Q4 '25: 682K Q1 '26: 708K Q2 '26: 505K Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '14: -157K Q2 '14: -229K Q3 '14: -267K Q4 '14: -247K Q1 '15: -299K Q2 '15: -537K Q3 '15: -264K Q4 '15: -380K Q1 '16: -362K Q2 '16: -478K Q3 '16: -267K Q4 '16: -426K Q1 '17: -405K Q2 '17: -514K Q3 '17: -483K Q4 '17: -780K Q1 '18: -867K Q2 '18: -1M Q3 '18: -797K Q4 '18: -881K Q1 '19: -937K Q2 '19: -792K Q3 '19: -1.1M Q4 '19: -1M Q1 '20: -895K Q2 '20: -483K Q3 '20: -695K Q4 '20: -1.3M Q1 '21: -954K Q2 '21: -1.9M Q3 '21: -634K Q4 '21: -863K Q1 '22: -1.7M Q2 '22: -2M Q3 '22: -2M Q4 '22: -1.3M Q1 '23: -1.2M Q2 '23: -1.2M Q3 '23: -682K Q4 '23: -491K Q1 '24: -579K Q2 '24: -553K Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '14: -268K Q4 '14: -248K Q1 '15: -299K Q2 '15: -538K Q3 '15: -264K Q4 '15: -380K Q1 '16: -369K Q2 '16: -479K Q3 '16: -267K Q4 '16: -426K Q1 '17: -405K Q2 '17: -516K Q3 '17: -483K Q1 '18: -869K Q2 '18: -1M Q3 '18: -800K Q4 '18: -881K Q1 '21: -956K Q2 '21: -1.9M Q3 '21: -635K Q4 '21: -863K Q3 '22: -2M Q1 '23: -1.2M Q2 '23: -1.2M Q3 '23: -682K Q4 '23: -491K Q1 '24: -580K Q2 '24: -555K Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q3 '14 Q4 '15 Q1 '17 Q3 '18 Q4 '21 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '21: 24.2M Q2 '21: 24.8M Q3 '21: 26.1M Q1 '22: 1.4M Q2 '22: 1.4M Q3 '22: 1.4M Q1 '23: 1.7M Q2 '23: 1.7M Q3 '23: 1.7M Q1 '24: 247K Q2 '24: 25.3K Q3 '24: 280.3K Q1 '25: 62.6K Q2 '25: 484.6K Q3 '25: 858.4K Q1 '26: 3.3M Q2 '26: 6.2M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-210.00 -140.00 -70.00 0.00 70.00 140.00 210.00 Q4 '14: -17.07 Q1 '15: -14.68 Q2 '15: -11.05 Q3 '15: -6.34 Q4 '15: -1.34 Q1 '16: -0.60 Q2 '16: -0.63 Q3 '16: -0.53 Q4 '16: -0.62 Q1 '17: -0.88 Q2 '17: -0.93 Q3 '17: -1.15 Q4 '17: -1.16 Q1 '18: -0.91 Q2 '18: -0.86 Q3 '18: -0.72 Q4 '18: -0.64 Q1 '19: -0.92 Q2 '19: -0.95 Q3 '19: -0.86 Q4 '19: -0.85 Q1 '20: -0.58 Q2 '20: -0.62 Q3 '20: -0.60 Q4 '20: -0.42 Q1 '21: -0.49 Q2 '21: -0.30 Q3 '21: -0.46 Q4 '21: -0.57 Q1 '22: -1.18 Q2 '22: -2.10 Q3 '22: -2.52 Q4 '22: -3.84 Q1 '23: -3.70 Q2 '23: -3.42 Q3 '23: -3.16 Q4 '23: -23.33 Q1 '24: -20.28 Q2 '24: -46.81 Q3 '24: -49.95 Q4 '24: -157.28 Q1 '25: -189.56 Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q1 '22 Q3 '23 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.